SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

Corcept Therapeutics Initiates Phase 3 Trial Of Relacorilant In Patients With Cushing's Syndrome Of Adrenal Origin

Benzinga · -